Get App Open
In App
Lending
Lending
Open App
you are here:

Emcure Pharmaceuticals Ltd.

BSE: 544210 | NSE: EMCURE |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE168P01015 | SECTOR: Pharmaceuticals & Drugs

BSE Live

Sep 05, 16:01
1376.80 6.90 (0.50%)
Volume
AVERAGE VOLUME
5-Day
9,643
10-Day
21,578
30-Day
18,067
3,232
  • Prev. Close

    1369.90

  • Open Price

    1371.00

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

NSE Live

Sep 05, 15:58
1372.70 2.00 (0.15%)
Volume
AVERAGE VOLUME
5-Day
309,849
10-Day
278,852
30-Day
210,353
57,848
  • Prev. Close

    1370.70

  • Open Price

    1369.10

  • Bid Price (Qty.)

    1372.70 (26)

  • Offer Price (Qty.)

    0.00 (0)

Financials

Profit & Loss account of Emcure Pharmaceuticals (in Rs. Cr.) Mar 25 Mar 24 Mar 23 Mar 22  
  12 mths 12 mths 12 mths 12 mths  
INCOME  
Revenue From Operations [Gross] 7,808.27 6,581.99 5,931.08 5,766.20  
Less: Excise/Sevice Tax/Other Levies 0.00 0.00 0.00 0.00  
Revenue From Operations [Net] 7,808.27 6,581.99 5,931.08 5,766.20  
Total Operating Revenues 7,896.00 6,658.25 5,985.81 5,855.39  
Other Income 67.26 56.99 45.91 63.47  
Total Revenue 7,963.26 6,715.24 6,031.72 5,918.86  
EXPENSES  
Cost Of Materials Consumed 1,526.90 1,333.13 1,146.59 1,296.10  
Purchase Of Stock-In Trade 1,883.24 1,332.48 1,047.25 1,082.45  
Operating And Direct Expenses 0.00 0.00 0.00 0.00  
Changes In Inventories Of FGWIP And Stock In Trade -263.53 -190.19 66.69 -145.40  
Employee Benefit Expenses 1,446.29 1,292.08 1,117.33 1,011.82  
Finance Costs 175.78 237.15 213.61 175.98  
Depreciation And Amortisation Expenses 384.13 312.41 260.12 244.86  
Other Expenses 1,828.72 1,661.03 1,426.77 1,280.50  
Total Expenses 6,981.53 5,978.08 5,278.36 4,946.31  
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax 981.73 737.16 753.36 972.55  
Exceptional Items -10.38 -9.93 -6.15 0.00  
Profit/Loss Before Tax 971.35 727.23 747.22 972.55  
Tax Expenses-Continued Operations  
Current Tax 292.16 209.64 173.30 286.05  
Less: MAT Credit Entitlement 0.00 0.00 0.00 0.00  
Deferred Tax -28.28 -9.99 12.07 -16.06  
Other Direct Taxes 0.00 0.00 0.00 0.00  
Total Tax Expenses 263.88 199.65 185.37 269.99  
Profit/Loss After Tax And Before ExtraOrdinary Items 707.47 527.58 561.85 702.56  
Profit/Loss From Continuing Operations 707.47 527.58 561.85 702.56  
Profit/Loss For The Period 707.47 527.58 561.85 702.56  
Minority Interest -26.14 -29.39 -29.83 -40.36  
Consolidated Profit/Loss After MI And Associates 681.33 498.18 532.02 662.20  
OTHER ADDITIONAL INFORMATION  
EARNINGS PER SHARE  
Basic EPS (Rs.) 36.00 28.00 29.00 37.00  
Diluted EPS (Rs.) 36.00 28.00 29.00 37.00  
DIVIDEND AND DIVIDEND PERCENTAGE  
Equity Share Dividend 0.00 54.26 36.17 54.26  
Tax On Dividend 0.00 0.00 0.00 0.00  
Source : Dion Global Solutions Limited

Results of Pharmaceuticals & Drugs Sector

  • 01.01.1970

  • 01.01.1970

  • 01.01.1970

  • 01.01.1970